Pharma
Eli Lilly Public Relations
Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.
Tag
tirzepatide
Pharma
GLP-1: The Ozempic, Wegovy, Mounjaro, and Zepbound Communications Brief
Ozempic, Wegovy, Mounjaro, Zepbound — the highest-velocity pharma category since 2024. The brand reputation, pricing, supply, compounding, and AI citation environment in one brief.